Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 27:5:123.
doi: 10.3389/fphar.2014.00123. eCollection 2014.

Fibroblasts in fibrosis: novel roles and mediators

Affiliations
Review

Fibroblasts in fibrosis: novel roles and mediators

Ryan T Kendall et al. Front Pharmacol. .

Abstract

Fibroblasts are the most common cell type of the connective tissues found throughout the body and the principal source of the extensive extracellular matrix (ECM) characteristic of these tissues. They are also the central mediators of the pathological fibrotic accumulation of ECM and the cellular proliferation and differentiation that occurs in response to prolonged tissue injury and chronic inflammation. The transformation of the fibroblast cell lineage involves classical developmental signaling programs and includes a surprisingly diverse range of precursor cell types-most notably, myofibroblasts that are the apex of the fibrotic phenotype. Myofibroblasts display exaggerated ECM production; constitutively secrete and are hypersensitive to chemical signals such as cytokines, chemokines, and growth factors; and are endowed with a contractile apparatus allowing them to manipulate the ECM fibers physically to close open wounds. In addition to ECM production, fibroblasts have multiple concomitant biological roles, such as in wound healing, inflammation, and angiogenesis, which are each interwoven with the process of fibrosis. We now recognize many common fibroblast-related features across various physiological and pathological protracted processes. Indeed, a new appreciation has emerged for the role of non-cancerous fibroblast interactions with tumors in cancer progression. Although the predominant current clinical treatments of fibrosis involve non-specific immunosuppressive and anti-proliferative drugs, a variety of potential therapies under investigation specifically target fibroblast biology.

Keywords: endostatin; extracellular matrix; fibroblast; fibrosis; idiopathic pulmonary fibrosis; myofibroblast; scleroderma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of factors involved with the promotion of a profibrotic myofibroblast phenotype.
Figure 2
Figure 2
Myofibroblasts can differentiate from a variety of precursor cell types.

Similar articles

Cited by

References

    1. Abdalla M., Goc A., Segar L., Somanath P. R. (2013). Akt1 mediates alpha-smooth muscle actin expression and myofibroblast differentiation via myocardin and serum response factor. J. Biol. Chem. 288, 33483–33493 10.1074/jbc.M113.504290 - DOI - PMC - PubMed
    1. Abraham D. J., Varga J. (2005). Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol. 26, 587–595 10.1016/j.it.2005.09.004 - DOI - PubMed
    1. Akhmetshina A., Palumbo K., Dees C., Bergmann C., Venalis P., Zerr P., et al. (2012). Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat. Commun. 3, 735 10.1038/ncomms1734 - DOI - PMC - PubMed
    1. Akita S., Kubota K., Kobayashi A., Misawa R., Shimizu A., Nakata T., et al. (2012). Role of bone marrow cells in the development of pancreatic fibrosis in a rat model of pancreatitis induced by a choline-deficient/ethionine-supplemented diet. Biochem. Biophys. Res. Commun. 420, 743–749 10.1016/j.bbrc.2012.03.060 - DOI - PubMed
    1. Amara N., Goven D., Prost F., Muloway R., Crestani B., Boczkowski J. (2010). NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65, 733–738 10.1136/thx.2009.113456 - DOI - PMC - PubMed